GSDMD and endometrial cancer: Therefore, we hypothesize that GSDMD is the terminal protein in the pyroptotic sequence in endometrial cancer cells, and that GSDMD-mediated IL-1β secretion occurs via the ROS-NLRP3-caspase-1 signaling pathway is induced by activating effector molecular hydrogen.